Compare · BFLY vs GEHC
BFLY vs GEHC
Side-by-side comparison of Butterfly Network Inc. (BFLY) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $27.76B, about 19.6x BFLY ($1.41B).
- GEHC has been more active in the news (14 items in the past 4 weeks vs 9 for BFLY).
- GEHC has more recent analyst coverage (25 ratings vs 8 for BFLY).
- Company
- Butterfly Network Inc.
- GE HealthCare Technologies Inc.
- Price
- $5.39+12.53%
- $61.01+0.33%
- Market cap
- $1.41B
- $27.76B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 9
- 14
- Recent ratings
- 8
- 25
BFLY
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Latest BFLY
- Chief Business Officer Cashman Steve sold $724,166 worth of shares (147,518 units at $4.91), decreasing direct ownership by 7% to 2,029,868 units (SEC Form 4) (tax liability)
- SEC Form 10-Q filed by Butterfly Network Inc.
- Butterfly Network Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Butterfly Network Reports First Quarter 2026 Financial Results
- SEC Form DEFA14A filed by Butterfly Network Inc.
- SEC Form DEF 14A filed by Butterfly Network Inc.
- Butterfly Network Appoints Arun Nagdev, MD as Chief Medical Officer – POCUS
- SEC Form 4 filed by Cashman Steve
- Butterfly Network to Report First Quarter 2026 Financial Results on April 30, 2026
- Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Tool, Marking a Major Stride for Women's Health
Latest GEHC
- Chief Financial Officer Saccaro James bought $200,585 worth of shares (3,310 units at $60.60), increasing direct ownership by 4% to 87,471 units (SEC Form 4)
- GC & Corporate Secretary Jimenez Frank R bought $105,788 worth of shares (1,750 units at $60.45), increasing direct ownership by 2% to 93,932 units (SEC Form 4)
- President and CEO Arduini Peter J bought $249,827 worth of shares (4,169 units at $59.92), increasing direct ownership by 2% to 259,424 units (SEC Form 4)
- GE HealthCare downgraded by Goldman with a new price target
- SEC Form 10-Q filed by GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GE HealthCare reports first quarter 2026 financial results
- GE HealthCare announces executive team and operational updates to enhance execution, accelerate innovation, and drive growth
- GE HealthCare management to present at upcoming investor conferences
- GE HealthCare Announces First Patient Dosed in Phase 2/3 LUMINA Trial for Manganese-Based MRI Contrast Agent Under FDA Fast Track Designation, Further Advancing Its Innovation Pipeline of Novel Imaging Agents